The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Appetite regulation: from the gut to the hypothalamus
Abstract
Obesity is a serious medical condition whose prevalence is rising. Figures from the Health Survey for England show that, in 1980, 8% of women and 6% of men were classified as obese, as defined by a body mass index (BMI) of greater than 30 kg/m2. By 2001, these proportions had increased to 26% and 22%, respectively, with 55% of women and 66% of men being overweight (BMI > 25 kg/m2; Health Survey for England, 2001), reflecting a worldwide trend which is most marked in, but not restricted to, the developed world. Most of us in affluent countries live in a privileged land of plenty where high calorie foods are easily available and in which we have a limited need for exercise. The rising prevalence of obesity in children is of particular concern (Chinn & Rona, 2001). Obesity is associated with significant morbidity and mortality, which can be attributed to increased risk of a number of medical conditions (Kopelman, 2000) including type II diabetes mellitus, hypertension and coronary heart disease, the most common cause of premature mortality in the obese population. Less well known are the associations between obesity and several cancers including breast, endometrial, prostate and bowel cancer (Daling et al., 2001). Obesity predisposes to osteoarthritis particularly in the large weight-bearing joints and to respiratory problems including obstructive sleep apnoea. Thus obesity poses an immense and increasing public health burden. Despite the increase in population obesity described above, it should not be forgotten , in individual people, energy balance is usually very precise. Daily intake of food is highly variable and correlates poorly with energy expenditure, whereas over longer periods body weight is stable in most adults (Edholm, 1977). In this article, we will explore how appetite and food intake are regulated peripherally by adipose tissue and the gastrointestinal tract, and how these signals are relayed in the hypothalamus (Fig. 1). We will discuss which of these pathways might be pharmacologically manipulated. Circulating gastrointestinal and adipocyte hormones and neuronal circuits involved in energy homeostasis. Solid lines represent net stimulatory effect, dashed lines represent net inhibitory effect. Almost 50 years ago, Kennedy (1953) postulated that there was a circulating factor, related to or arising from adipose tissue, that regulated the hypothalamic control of food intake to achieve the usual long-term stability of body weight and fat mass. Insulin was the first hormone postulated to be such a factor. The rise in circulating insulin in response to a glucose load is proportional to fat mass, and insulin reaches the CNS via receptor-mediated transport across the blood–brain barrier. CNS administration of insulin to rodents, either into the third ventricle or directly into the hypothalamus, causes a reduction in food intake (Baura et al., 1993). However, patients with type II diabetes who are commenced on insulin tend to gain rather than lose weight, probably as a result of a loss of the anorexigenic effect of hyperglycaemia and the lipogenic actions of insulin. In 1994 there was a major breakthrough when the obese (ob) gene was identified from examination of naturally occurring mutant ob/ob mice (Zhang et al., 1994). The protein encoded by the ob gene was named leptin from the Greek leptos meaning thin, synthesized predominantly in adipose tissue. Circulating leptin levels are directly proportional to adiposity in animals and humans and correlate better with total fat mass than with body weight (Considine et al., 1996). Central and peripheral administration of leptin in rodents cause a profound decrease in food intake and weight loss (Friedman & Halaas, 1998). However it is the central intracerebroventricular (ICV) route that is the more potent, suggesting that leptin's actions are mediated chiefly through the hypothalamus. The ob/ob mouse, completely deficient in leptin, is hyperphagic, hyperinsulinaemic and very obese and the leptin receptor defective db/db mouse has a similar phenotype (Chua et al., 1996). Chronic administration of leptin to the ob/ob mouse results in sustained reduction in body weight, and reduced food intake but has no effect on the db/db mouse. Leptin increases hours after a meal in rodents and after several days of overeating in humans (Kolaczynski et al., 1996). Conversely, leptin levels fall dramatically with fasting. The magnitude of these responses is disproportionate to changes in fat mass, suggesting that leptin may act to stabilize body weight before a major change in weight occurs. In starvation, in which leptin levels are further reduced, there is activation of the hypothalamo–pituitary axis (HPA) and suppression of reproduction, the thyroid axis and the immune system (Ahima et al., 1996; Lord et al., 1998). When leptin is administered in the fasting state, these effects are blunted. Thus leptin plays a key role in signalling and survival in times of food depriv
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
A role for ghrelin in the central regulation of feeding
Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K., & Matsukura, S. (2001) · Nature · doi:10.1038/35051587 · Cited by 3,443
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E., & Weigle, D. S. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1714 · Cited by 2,940
Ghrelin enhances appetite and increases food intake in humans
Wren, A. M., Seal, L. J., Cohen, M. A., Brynes, A. E., Frost, G. S., Murphy, K. G., Dhillo, W. S., Ghatei, M. A., & Bloom, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8111 · Cited by 2,494
Self-citationLeptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdán, M. G., Diano, S., Horvath, T. L., Cone, R. D., & Low, M. J. (2001) · Nature · doi:10.1038/35078085 · Cited by 2,356
Gut hormone PYY3-36 physiologically inhibits food intake
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature · doi:10.1038/nature00887 · Cited by 2,351
Self-citation
Cited by
Ghrelin: Structure and Function
Kojima, M., & Kangawa, K. (2005) · Physiological Reviews · doi:10.1152/physrev.00012.2004 · Cited by 2,810
Neuropeptides and the control of food intake in fish
Volkoff, H., Canosa, L. F., Unniappan, S., Cerdá-Reverter, J. M., Bernier, N. J., Kelly, S. P., & Peter, R. E. (2005) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2004.11.001 · Cited by 584
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint
Wischhusen, J., Melero, I., & Fridman, W. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00951 · Cited by 506
Role of neuropeptides in appetite regulation and obesity – A review
Arora, S., & Anubhuti (2006) · Neuropeptides · doi:10.1016/j.npep.2006.07.001 · Cited by 455
Prader-Willi syndrome: advances in genetics, pathophysiology and treatment
Goldstone, A. P. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2003.11.003 · Cited by 393
Self-citation
Metadata
- Authors
- Neary, N. M., Goldstone, A. P., & Bloom, S. R.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2003-11-18
- Volume
- 60
- Issue
- 2
- Pages
- 153-160
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2061829356
- Cited by
- 193
- References
- 16
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Appetite regulation: from the gut to the hypothalamus. https://app.cochat.ai/papers/10.1046/j.1365-2265.2003.01839.x
- The paper
- Neary, N. M., Goldstone, A. P., & Bloom, S. R. (2004). Appetite regulation: from the gut to the hypothalamus. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2003.01839.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.